Plano’s AllerVie Health Appoints New Chief Executive Officer

Tae Kim's promotion from president reflects the company's strategic plan, AllerVie said. Kim began his career in healthcare in investment banking at Goldman Sachs.

Plano-based AllerVie Health announced that Tae Kim will be the new chief executive officer of the national network of allergy clinics.

Kim’s promotion from president reflects the company’s strategic plan, AllerVie said.

Chris Roussos, executive chairman of the board and former chief executive officer, will continue in his role on AllerVie’s board as executive chairman, where he remains actively engaged in key strategic activities on behalf of the company, AllerVie said.

“I’ve had the privilege of working with and mentoring Tae since we partnered for the incredibly successful sale of Epic Health Services in 2016. His exemplary leadership, invaluable strategic insight, and unwavering commitment to our mission of improving healthcare services have been instrumental in establishing our position as a frontrunner in the allergy and asthma industry,” Roussos said in a statement.

“Collaborating with Tae, I’ve seen firsthand how his understanding of the industry and ability to structure meaningful partnerships between physicians, the allergy community, and our organization have been critical to our success.”

‘Positive change’ in the allergy industry

Kim joined AllerVie as chief operating officer in 2021 and has focused extensively on aligning physicians’ goals with AllerVie’s growth strategies and creating partnerships designed to forward the objectives of both clinicians and patients, the company said.

Kim’s approach has propelled AllerVie from nine clinics and eight physicians in 2020 to nearly 80 clinics and 100 providers by the end of 2023, AllerVie said.

Before AllerVie, Kim was the chief operating officer and chief financial officer at Martin UAV, an aerospace technology company.

That company experienced significant growth under his leadership, culminating in a successful acquisition by Shield AI, a leading AI defense technology company.

Kim began his career in healthcare in investment banking at Goldman Sachs, focusing on healthcare mergers & acquisitions, equity raises, debt financing, and corporate advisory.

“Over the last three and a half years, Chris has laid an incredible foundation expanding AllerVie’s nationwide footprint, focusing our overarching objectives, and establishing the vision and team to execute AllerVie’s impact on allergy, asthma, and immunology on a national scale,” Kim said in a statement.

“I’m looking forward to taking on the role as CEO and continuing AllerVie’s mission to redefine care and access in this specialty, setting new standards in healthcare excellence and innovation to exceed patient expectations. As Chris always does, he’s built a world-class team at AllerVie. I am honored to continue working with him in our new roles to advance the experience and propel positive change for our patients, physicians, and the allergy industry.”

Get on the list.
Dallas Innovates, every day.

Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.

One quick signup, and you’re done.  

R E A D   N E X T

  • Keith Scally has joined Richardson-based Cariloop, a comprehensive caregiver support platform that combines cloud-based tools and personalized, professional coaching services, as chief product officer. The company said that Scally will oversee its tech-enabled, human-powered innovation initiatives as they continue to create game-changing solutions that reduce the stress and burden felt by working caregivers and families. “Keith is a phenomenal product leader and brings a wealth of knowledge and experience to our team. He has such a bold, creative vision and a fierce passion for building products that have the potential to help families on a global scale,” CEO Michael Walsh…

  • ISN, the Dallas-based global provider of contractor and supplier information management, has named Brian Callahan as chief executive officer as part of a planned leadership transition. The company said Callahan succeeds Joe Eastin, who now serves as executive chairman. In a recent statement, the newly appointed CEO of ISN expressed deep honor and gratitude for the opportunity to lead the company, acknowledging the significant influence and mentorship of Eastin.  "I am grateful to Joe Eastin for his leadership, mentorship, and friendship over the past 20 years and look forward to working with him in his new role as Executive Chairman,"…

  • Larry Nabb has been appointed chief executive officer of Jet Health Inc., a Fort Worth-based regional provider of home health, hospice, and personal care services. He replaces Stacie Bratcher, who was CEO since March 2020. Jim Glynn, Jet Health's founder and board chair, recently expressed his confidence in the company's new appointment, Nabb. Described as a skilled strategic leader, Nabb comes with a wealth of operational experience and an aptitude for inspiring growth and engagement in the teams he's led. "Jet Health’s board of directors believes [his] extensive industry expertise and proven track record will position him for success in…

  • Formerly AllerVie’s chief medical officer, Dr. Weily Soong will lead efforts to drive innovation with new therapies and diagnostics for asthma, allergies, and other related immunological conditions at AllerVie Clinical Research.

  • Dallas' Ventra Health Adds New Chief Transformation Officer

    Ventra Health, the Dallas-based business solutions provider for hospital-based clinicians, has named Erica Franko chief transformation officer. An experienced financial and operations improvement executive, Franko brings to the job more than a decade of experience with industry-leading consulting and healthcare companies. "I am thrilled to welcome Erica to our team. She has proven experience centered at the intersection of technology and process, which will help us to better focus on driving sustainable improvements that will allow us to optimize how we serve our clinician partners," CEO Steven Huddleston said in a statement. During her career, Franko has focused on transforming…